SABio’s founder A/Prof. Subhash Vasudevan (Duke-NUS), who researched Celgosivir since 2007 as a means to fight dengue, was one of the initiators of the trial. The drug was initially developed for other infectious diseases like HIV, and was not used to treat dengue fever until now. “We are taking an old drug and asking if there is a new use for it,” said A/Prof. Subhash Vasudevan . “There are no antiviral drugs ready to go into clinical trials against dengue at this point, except for this one”.

Pending the outcome of clinical trials, Celgosivir may become the world’s first drug to treat dengue fever. Currently, only  supportive treatment is available for dengue. About 5,330 dengue cases were reported in Singapore last year, and up to 100 million people are infected annually worldwide.

More information about CELADEN clinical trial can be found at www.celaden.sg .

SABio now sells siRNA to Australia and New Zealand! Our Aussie and NZ customers get their siRNA within 7-10 days from placing their order.  Quality is guaranteed (or your money back), shipping is FREE, and prices are unbeatable! Give us a try and get a quotation for your siRNA of interest at orders@sabio.com.sg . Prices will be conveniently quoted in AUD or NZD, thus ordering is always a breeze!